
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum is expected to see growth in both its MedSurg and Dental segments, driven by ongoing demand for key products and expansion into new markets. The company's focus on digital capabilities and data science also positions it well for future growth and innovation within the healthcare industry. Furthermore, potential divestiture in non-core product areas could further optimize Solventum's portfolio and improve its financial performance. This, combined with potential M&A activity and pricing strategies, could result in increased revenue and margins for the company. However, there are some potential risks, such as competition and regulatory actions, that could impact Solventum's growth and stock performance. Overall, with a promising financial outlook and a strong product portfolio, Solventum appears to be a good investment opportunity for the long-term.
Bears say
Solventum is facing potential downsides in its key segments due to lower organic growth, slower improvement in operat
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares